Related Experiment Video
Updated: Aug 6, 2026

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
Published on: September 1, 2023
Self-amplifying mRNA vaccine cocktail against Staphylococcus aureus: A multi-epitope immunoinformatics and structural
Aysan Salemi1, Mohammad M Pourseif2,3,4, Behzad Jafari5
1Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
This study designed a bivalent self-amplifying mRNA (saRNA) vaccine cocktail against Staphylococcus aureus. Computational analysis indicates the candidate vaccines, SaBVax807 and SaTVax876, show promise for preventing S. aureus infections.
Area of Science:
- Vaccinology
- Computational Biology
- Infectious Disease
Background:
- Staphylococcus aureus (S. aureus) poses a significant global health risk, with no licensed human vaccines currently available.
- There is an urgent need for effective non-antibiotic prophylactic strategies against invasive S. aureus infections.
Purpose of the Study:
- To design and computationally evaluate a bivalent self-amplifying mRNA (saRNA) vaccine cocktail targeting key S. aureus virulence factors (ClfA, Hly, SraP).
- To assess the safety, stability, and immunogenic potential of the candidate saRNA vaccines (SaBVax807 and SaTVax876) using a multi-method computational pipeline.
Main Methods:
- Utilized immunoinformatics, structural bioinformatics, and molecular simulations to identify immunodominant epitopes and design saRNA constructs.
- Performed molecular docking and dynamics simulations to validate antigen-antibody and antigen-HLA interactions.
- Conducted codon optimization for human cells and assessed vaccine candidates for safety, stability, and immunogenicity via in silico analyses.
Main Results:
- Successfully designed two saRNA vaccine candidates, SaBVax807 and SaTVax876, targeting S. aureus virulence antigens.
- Computational validation confirmed favorable binding interactions with antibodies and HLA alleles.
- In silico evaluations indicated favorable safety, structural stability, and predicted immunogenicity for the saRNA vaccine cocktail.
Conclusions:
- The designed saRNA vaccine cocktail demonstrates promising computational safety, stability, and immunogenic profiles against S. aureus.
- This study provides a strong in silico foundation for the development of novel S. aureus vaccines, guiding future preclinical and clinical research.
More Related Videos
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
10:58Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019